I
InterCure Ltd
TASE:INCR
InterCure Ltd
TASE:INCR
Price:
285.6
ILS
-0.76%
Market Cap:
₪137.3m
Relative Value
The Relative Value of one INCR stock under the Base Case scenario is 758.96 ILS. Compared to the current market price of 285.6 ILS, InterCure Ltd is Undervalued by 62%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
INCR
Relative Value
Base Case
758.96
ILS
Undervaluation 62%
I
Multiples Across Competitors
INCR Competitors Multiples
InterCure Ltd Competitors
InterCure Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
I
|
InterCure Ltd
TASE:INCR
|
138.4m ILS | 0.4 | -2.2 | 3.1 | 4.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.8B USD | 14.9 | 47.2 | 31.8 | 33.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
277B CHF | 4.5 | 29.7 | 12.6 | 14.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.5B CHF | 5.3 | 21.5 | 13.2 | 17 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
219.8B GBP | 5.3 | 33 | 15.7 | 23 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.2B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.8B USD | 2.6 | 17.5 | 6.9 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
